MORGANTE, Letterio
 Distribuzione geografica
Continente #
NA - Nord America 5.713
EU - Europa 5.404
AS - Asia 3.016
SA - Sud America 1.235
AF - Africa 110
Continente sconosciuto - Info sul continente non disponibili 49
OC - Oceania 17
Totale 15.544
Nazione #
US - Stati Uniti d'America 5.577
RU - Federazione Russa 2.797
SG - Singapore 1.297
BR - Brasile 1.069
CN - Cina 838
IE - Irlanda 714
SE - Svezia 492
UA - Ucraina 369
HK - Hong Kong 318
DE - Germania 308
IT - Italia 205
VN - Vietnam 190
FR - Francia 171
FI - Finlandia 154
GB - Regno Unito 114
IN - India 71
AR - Argentina 61
CA - Canada 47
BD - Bangladesh 41
TR - Turchia 41
MX - Messico 31
ZA - Sudafrica 30
EC - Ecuador 29
IQ - Iraq 29
CI - Costa d'Avorio 27
ID - Indonesia 24
PK - Pakistan 22
UZ - Uzbekistan 22
MA - Marocco 18
NL - Olanda 17
VE - Venezuela 16
CO - Colombia 15
AU - Australia 14
BE - Belgio 14
IR - Iran 14
JP - Giappone 13
PY - Paraguay 13
JM - Giamaica 12
UY - Uruguay 12
AT - Austria 11
PL - Polonia 10
CL - Cile 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
CR - Costa Rica 8
ES - Italia 8
EG - Egitto 7
JO - Giordania 7
KE - Kenya 7
DO - Repubblica Dominicana 6
HN - Honduras 6
IL - Israele 6
KG - Kirghizistan 6
LB - Libano 6
NP - Nepal 6
OM - Oman 6
PE - Perù 6
SA - Arabia Saudita 6
SV - El Salvador 6
BH - Bahrain 5
BO - Bolivia 5
TN - Tunisia 5
ET - Etiopia 4
GT - Guatemala 4
KZ - Kazakistan 4
NI - Nicaragua 4
RO - Romania 4
TT - Trinidad e Tobago 4
PR - Porto Rico 3
SN - Senegal 3
AM - Armenia 2
AO - Angola 2
BW - Botswana 2
CG - Congo 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
GP - Guadalupe 2
LV - Lettonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BZ - Belize 1
DK - Danimarca 1
GR - Grecia 1
HU - Ungheria 1
KI - Kiribati 1
Totale 15.491
Città #
Moscow 895
Jacksonville 766
Dublin 713
Singapore 623
Ashburn 602
Chandler 460
Dallas 448
Beijing 342
Hong Kong 318
Nyköping 279
Council Bluffs 263
San Jose 251
Princeton 145
Cambridge 141
Dearborn 140
The Dalles 137
Medford 132
Lauterbourg 129
Des Moines 109
Boardman 94
Los Angeles 90
São Paulo 73
Buffalo 65
Ann Arbor 61
Ho Chi Minh City 56
New York 52
Tianjin 41
Woodbridge 41
Wilmington 36
Rio de Janeiro 34
Belo Horizonte 33
Columbus 31
Hanoi 29
Guangzhou 27
Redondo Beach 27
Abidjan 26
Jinan 26
Dong Ket 24
San Mateo 24
Santa Clara 23
Orem 21
Brasília 20
Shenyang 20
Tashkent 19
Frankfurt am Main 18
Munich 18
Porto Alegre 18
Baghdad 17
Phoenix 17
Atlanta 15
Brooklyn 15
Johannesburg 15
Lancaster 15
Montreal 15
Curitiba 14
Brussels 13
Campinas 13
Carrboro 13
Chennai 13
Chicago 13
Hebei 13
Nanjing 13
Shanghai 13
Shenzhen 13
Dhaka 12
Düsseldorf 12
Houston 12
Tokyo 12
Guayaquil 11
Ningbo 11
Pune 11
Quito 11
Santo André 11
Sydney 11
Fuzhou 10
Hangzhou 10
Leawood 10
Montevideo 10
Mumbai 10
Nuremberg 10
Ribeirão Preto 10
Rome 10
Ardabil 9
Boston 9
Goiânia 9
Haikou 9
Istanbul 9
Kingston 9
Maceió 9
Milan 9
Norwalk 9
Viamão 9
Zhengzhou 9
Asunción 8
Charlotte 8
Denver 8
Las Vegas 8
London 8
Salvador 8
San Francisco 8
Totale 8.529
Nome #
Cognitive and mood disorders in elderly patients with Parkinson's disease 197
Fahr's syndrome: local inflammatory factors in the pathogenesis of calcification 187
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 182
Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease 180
Association study between the LINGO1 gene and Parkinson's disease in the Italian population 180
Efficacia e tollerabilità della quetiapina vs. clozapina in pazienti anziani parkinsoniani con psicosi dopaminergica. 179
Fumo di sigaretta e malattia di Parkinson (MP): osservazioni in un gruppo di pazienti anziani con MP. 178
Association study between The Lingo1 gene and Parkinson’s disease in the italian population. 175
Continuous apomorphine infusion and neuropsychiatric: a controlled study disorders in patients with advanced Parkinson’s disease: A four years follow-up. 175
Burden of cardiovascular disease in elderly with Parkinson's disease who start a dopamine agonist agent 169
Epidemiologia decrittiva della malattia di Parkinson. 166
Levetiracetam in tardive dyskinesia 166
L'anziano fragile con malattia di Parkinson e parkinsonismo. 164
Effetti comportamentali dell‘assunzione di L-Dopa in volontari sani. 158
Door-to-door prevalence survey of epilepsy in three Sicilian municipalities 157
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years 157
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton pleasure scale and its application in the clinical routine practice during the PRIAMO study. 157
Continuous apomorphine infusion and neuropsychiatric disorders in patients with Parkinson’s disease 153
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis 152
Speech and gait in Parkinson's disease: When rhythm matters 150
Psicomotricità nella malattia di Parkinson 150
Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test 148
Stuttering speech disorder is related to freezing of gait in Parkinson's disease 148
Unilateral cerebellar stroke disrupts movement preparation and motor imagery 145
Assessment of tolerability and eeicacy of duloxetine in the treatment of depressed patients with Parkinson’s disease. 144
A case control study on the association between Parkinson's disease (PD) and non fatal cancer after PD onset. 143
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire 143
Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Arcipelago, Sicily. 142
A screening instrument for a Sicilian neuroepidemiological survey in the elderly 141
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. 140
Evaluation of cognitive and affective status in elderly patients with Parkinson’s disease 140
Alprazolam versus amitriptiline in the treatment of patients with depressive neurosis 140
Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: Implications for mortality studies 139
Quetiapine and clozapine treatment of dopaminergic psychosis in Parkinson's disease 138
ATTRITION AND USE OF PROXY RESPONDENTS AND AUXILIARY INFORMATION IN THE SICILIAN NEUROEPIDEMIOLOGIC STUDY 136
Age at menopause predicts age at onset of Parkinson's disease. 133
A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease 132
CARDIAC MIBG SCINTIGRAPHY FOR DIFFERENTIATION OF THE PRIMARY PROGRESSIVE FREEZING GAIT FROM PD 132
Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease 131
Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. 131
Association of tau gene polymorphism with Parkinson's disease 130
accuracy of death certificate diagnosis for amyotrophic lateral sclerosi changes significantly from north to south italy: implications for mortality study 129
Alchol Intake, Cigarette Smoking and Coffee Consumption as Risk Factors for Parkinson's Disease 128
Effect of STN-DBS on impulse control disorder and other behavioral complications of Parkinson's disease: A 2-year longitudinal study 123
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 118
Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from parkinson's disease 118
Parkinson's disease, parkinsonism and aging 116
Clinical and Spect Dat-Scan Correlations od Drug-induced parkinsonism in patients with schizophrenia. An Italian Multicenter Study. Catania 23-27 ottobre 2010. Neurological Sciences 116
Prevalence of epilepsy in Lipari archipelago 115
PRIAMO study group. The priamo study: a multicenter assessment of nonmotor symptmos and their impact on quality of life in Parkinson's disease 111
The FRAGAMP study: environmental and genetic factors in Parkinson's disease, methods and clinical features 111
Long Term survival and outcome after first stroke in the Sicilian Aeolian Island Archipelago population. 109
Tumor diagnosis preceding Parkinson's disease: A case-control study 109
Myocardial(123)-IMBG scintigraphy for differentiation of Lewy bodies disease from FTD. 109
Incidence and lifetime prevalence of Bell's palsy in two Sicilian municipalities 108
Fahr's disease 107
Voluptuary habits and clinical subtypes of Parkinson's disease: the FRAGAMP case-control study 107
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression 107
Linee guida per il trattamento della malattia di Parkinson 2002 105
Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha 2 subunit associated with familial hemiplegic migraine type 2 105
Risk of cancer in patients with Parkinson's disease. 105
Stroke in the young in sicily: Prevalence and clinical features 105
The parkin gene is not involved in late-onset Parkinson's disease 104
Reproductive factors and Parkinson's disease: A multicenter case-control study 104
The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms. 102
Non motor symptoms and PD phenotypes. The Fragamp Study. 101
Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia 100
Stato cognitivo e tono dell’umore in soggetti anziani con malattia di Parkinson e parkinsonismo vascolare 100
Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS). 100
PERGOLIDE MONOTHERAPY IN TREATMENT OF EARLY PARKINSON'S DISEASE: A RANDOMIZED CONTROLLED STUDY 99
EPIDEMIOLOGY AND PATHOETIOLOGY OF NEUROLOGICAL SYNDROMES WITH HYPERTHERMIA 99
Parkinson disease survival - A population-based study 98
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease : A national multicenter parallel-group randomized study. 98
THE PARKIN GENE AND ITS PHENOTIPE 97
GUIDELINES FOR THE TREATMENT OF PARKINSON'S DISEASE 2002 97
PREVALENCE OF PARKINSONS-DISEASE AND OTHER TYPES OF PARKINSONISM - A DOOR-TO-DOOR SURVEY IN 3 SICILIAN MUNICIPALITIES 97
DOOR-TO-DOOR PREVALENCE SURVEY OF NEUROLOGICAL DISEASES IN A SICILIAN POPULATION - BACKGROUND AND METHODS 97
MYOCARDIAL MIBG SCINTIGRAPHY FOR DIFFERENTIATING LeWY BODIES DISEASE FROM FRONTOTEMPORAL DEMENTIA 97
Cardiac MIBG scintigraphy in Primary Progressive Freezing Gait. 97
Prevalence survey of major neurological disorders in Sicily: results of a pilot study 97
LINEE GUIDA PER IL TRATTAMENTO DELLA MALATTIA DI PARKINSON 2000 96
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. 95
MR Imaging of Middle Cerebellar Peduncle Width: Differentiation of Multiple System Atrophy from Parkinson Disease. 95
Deficit dell'inibizione afferente a breve latenza nelle discinesie levodopa indotte. 94
Prescribing pattern of anti-Parkinson drugs in Southern Italy: Cross-sectional analysis in the years 2003-2005. 94
Gynecomastia, hyperprolactinemia and on-off phenomena in a parkinsonian treated with L-dopa + benserazide 94
Highly disabling cerebellar presentation in Huntington disease 93
Height as a potential indicator of early life events predicting Parkinson's disease: a case-control study. 93
PREVALENCE OF ESSENTIAL TREMOR - A DOOR-TO-DOOR SURVEY IN TERRASINI, SICILY 91
Prescribing pattern of anti-Parkinson drugs in sourthen italy in the years 2003-2005. 90
Neuroleptic malignant syndrome: description of two cases with prolonged clinical course 90
Levodopa in the third millennium 89
Occupation, education, and Parkinson's disease: A case-control study in an Italian population 89
Lack of LTD-like plasticity in levodopa induced dyskinesia. 89
Validation of the Italian version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale 89
Familial hemiplegic migraine type 2 is linked to 0.9Mb region on chromosome 1q23 88
Linkage analysis in an Italian family with autosomal recessive hereditary spastic paraplegia 87
Prevalence of cervical spondylotic radiculopathy: A door-to- door survey in a Sicilian municipality 87
Wine drinking and essential tremor: A possible protective role 87
Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease 86
Totale 12.269
Categoria #
all - tutte 56.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022539 0 0 0 0 24 3 33 44 19 24 111 281
2022/20232.000 162 131 111 126 186 195 18 127 862 7 56 19
2023/2024385 46 96 38 26 42 72 2 4 0 10 7 42
2024/20252.435 29 25 39 110 140 37 28 635 688 162 115 427
2025/20266.207 223 455 488 484 497 1.520 651 768 744 189 93 95
2026/20271.265 107 292 328 526 12 0 0 0 0 0 0 0
Totale 15.544